FDA supports voluntary labeling of foods with biotech
As reported by POLITICO, Food and Drug Administration (FDA) Commissioner Margaret Hamburg reinforced the FDA's stance on the labeling of products containing biotechnology in a House Appropriations subcommittee meeting last Thursday.
FDA, according to Hamburg, supports voluntary labeling, but opposed mandatory labeling.
"Mandatory labeling really is appropriate when there is a fault claim," testified Hamburg. "The fact that a product contains GE ingredients does not change the material content of the product."
Hamburg went on to reiterate that in more than 20 years of commercialized biotech traits, the FDA has yet to find evidence of food safety risks.
- Monsanto invests to transform plant breeding
- Fungicide-resistant soybean diseases spreading
- Most crop futures are starting Thursday on a strong note
- Initiatives attack biotech on ballots in Colorado, Oregon, Maui
- Commentary: Ag’s leading role in the international marketplace
- Salt-loving plants may be key to sustainable food production
- ValueAct buys stake in fertilizer dealer Agrium
- Critics of Dow herbicide sue U.S. EPA over approval
- Six tips to help professionals take leaps of faith
- Nitrogen fertilization rates for corn production
- Landmark Services Co-op, Curry Seeds sign agreement
- No-till may not bring boost in global crop yields
- Los Angeles City Council votes to explore ban on GMO plants
- ASA issues statement on EPA’s neonicotinoid study
- Economist: Taxing P could reduce risk of algal blooms
- Commentary: Government wants farmers to quit farming
- Resistant weeds not controlled by fall residuals
- First responders need to prepare for agroterrorism